welcomes you to the new, improved website!More than minimally manipulated (MMM) allograft heart valves should be classified as high risk devices, requiring premarket approval including safety and efficacy studies, according to an FDA panel.
You are here:
FDA Panel: Engineered Donor Heart Valves Need PMA
Submitted by: Mark Ferguson
Source: MedPage Today
Keywords:
Author(s): Shannon Firth
